SR One's Simeon George on recent news from CRISPR, Turning Point (Bristol), Arcellx, and more

blonca9
Nov 22, 2023
1 min read

Simeon George talks about his firm's philosophy, advice for biotech entrepreneurs, and discusses Turning Point, Avenzo, CRISPR, Nkarta, Arcellx, ADARx, and Rezo Therapeutics.

Recent Posts

See All

RBC Global Healthcare Conference: Desk Strategist Chris McCarthy shares how institutional investors have been affected by policy and macro factors, and how they have been positioning around catalysts

RBC Global Healthcare Conference: Senior Biotech Analyst Luca Issi shares his thoughts on the current state of gene and cell therapy

RBC Global Healthcare Conference: RBC's Brian Abrahams shares his take on biotech and offers advice for companies on how to navigate these times of change

SR One's Simeon George on recent news from CRISPR, Turning Point (Bristol), Arcellx, and more

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight